Provided by Tiger Trade Technology Pte. Ltd.

3D MEDICINES

2.480
-0.115-4.43%
Volume:123.50K
Turnover:317.74K
Market Cap:639.84M
PE:-2.95
High:2.600
Open:2.590
Low:2.465
Close:2.595
52wk High:10.020
52wk Low:1.820
Shares:258.00M
HK Float Shares:258.00M
Volume Ratio:0.41
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.840
ROE:-29.62%
ROA:-11.98%
PB:0.92
PE(LYR):-2.95
PS:1.54

Loading ...

3D Medicines FY26 H1 Comprehensive Loss Narrows 4.47% to RMB 88.5 Million; Revenue Rises 0.6% to RMB 210.5 Million

Reuters
·
Yesterday

3D Medicines Shifts Cayman Registered Office to Harbour Place, Effective 16 June 2026

Bulletin Express
·
Aug 28

Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again

Stock News
·
Aug 20

3D Medicines Surges Over 55% Pre-Noon, Focusing on Cutting-Edge Global Oncology Advancements

Deep News
·
Aug 20

HK Movers | Pharma Stocks Surge With 3D Medicines up 68%, CanSino Biologics up 52%

Tiger Newspress
·
Aug 20

Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing

Stock News
·
Aug 20

Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation

Stock News
·
Aug 19

3D Medicines Says Arbitration Award From Sellas Life Sciences Fully Settled

MT Newswires Live
·
Aug 18

3D MEDICINES (01244) Confirms Full Receipt of HK$7.983 Million in Arbitration Cost Recovery from SELLAS

Stock News
·
Aug 18

3D Medicines Recovers HK$7.98 Million in Arbitration with SELLAS; 3D189 Trial Reaches 78 of 80 Target Events

Bulletin Express
·
Aug 18

3D Medicines - Arbitrator Dismisses All Sellas Claims; Orders Sellas to Pay HK$8 Mln in Costs

THOMSON REUTERS
·
Aug 18

3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend

Bulletin Express
·
Aug 17

3D Medicines Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 17

3D Medicines Announces Non-Executive Board Transition: Zhu Jinqiao to Retire, Zhang Wenhua Named Successor

Bulletin Express
·
Aug 07

3D Medicines Files Board, Board Committee Member List with Disclosure Roles

Reuters
·
Aug 07

3D Medicines Appoints Ms. Zhang Wenhua as New Non-Executive Director

Stock News
·
Aug 07

3D Medicines Maintains Stable Share Base in July 2026; Public Float Meets HKEX Requirements

Bulletin Express
·
Aug 06

3D Medicines to Replace Hong Kong Process Agent and Move Principal Office Effective 4 August 2026

Bulletin Express
·
Aug 04

3D Medicines Appoints New Agent for Legal Service in Hong Kong

Stock News
·
Aug 04

3D Medicines Names Leung Ching Ching as Hong Kong Process Agent, Replacing Li Ching Yi

Reuters
·
Aug 04